Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Opentrons
AddedFeb 13, 2024
UpdatedJul 17, 2026
Opentrons

Opentrons

Series C

Opentrons: Automating lab work with robots for biologists worldwide, enhancing research efficiency.

HQ
New York City, NY, US
Founded
2014
Accelerator
Y Combinator logoY CombinatorW16
Overview
Compare
Fundraising
Employees
Website

Opentrons, founded in 2014 by Nicholas Wagner, Will Canine, and Chiu Chau, aims to revolutionize lab work by automating tedious tasks for biologists. The company offers robotic solutions like OT-1, OT-2, and Flex, focusing on enhancing research efficiency and reproducibility. Based in Long Island City, New York, Opentrons serves the biotechnology, robotics, and automation markets.

Opentrons has made significant strides, including the commissioning of their robots in various institutions like the Regional Hospital of Málaga. With 328 employees as of 2023, the company has had a notable impact on the scientific community, enabling researchers to focus more on experimental design and data analysis. CEO Jon Brennan-Badal leads the company in its mission to streamline lab workflows globally.

Opentrons - Similar Companies

AbioBot logo

AbioBot

abiobot.io

Strateos logo

Strateos

strateos.com

New Lab logo

New Lab

Reshape Biotech logo

Reshape Biotech

reshapebiotech.com

BioNex Solutions logo

BioNex Solutions

Aqueduct Fluidics logo

Aqueduct Fluidics

Artificial logo

Artificial

artificial.com

Monomer Bio logo

Monomer Bio

monomerbio.com

CryoXtract Instruments logo

CryoXtract Instruments

cryoxtract.com

RobotLAB logo

RobotLAB

robotlab.com

Labsmith logo

Labsmith

labsmith.com

Lab Automate Technologies logo

Lab Automate Technologies

labautomate.net

LabGrid logo

LabGrid

Orangewood Labs logo

Orangewood Labs

orangewood.co

Quartzy logo

Quartzy

quartzy.com

Opentrons - Quick Facts

Who are Opentrons' competitors?

Companies similar to Opentrons include AbioBot, Strateos, New Lab and Reshape Biotech.

When was Opentrons founded?

Opentrons was founded in 2014.

Where is Opentrons' headquarters located?

Opentrons' headquarters is located in New York City, NY, US.

When was Opentrons' last funding round?

Opentrons' most recent funding round was for $200M (USD) in September 2021.

How much has Opentrons raised to-date?

As of Sep 23, 2021, Opentrons has raised a total of $240M (USD).

How many employees does Opentrons have?

Opentrons has 328 employees as of Feb 5, 2024.

Opentrons - Classification

Industry
  • Hardware
Ownership
  • Private
  • Venture Capital
Technology
  • Automation
  • Robotics
Geographic Exposure
  • Global
Revenue
  • Software
  • Transactional
Customer
  • Enterprise
  • Government
Main Product
  • Lab Automation
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7372Prepackaged Software
Show 6 more industry codes
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7371Computer Programming Services